According to this article in outsourcing-pharma.com the outsourcing sector in India is expected to grow at 43 percent due to the diminishing concerns of the about operations in that country. Predictions made by Ernst & Young show that India is still ranked highest among its outsourcing peers in cost efficiency. Also, the country's technological capabilities are far more advanced than many of the other competing countries. It will be interesting to see India will grow as expected, or if Eastern Europe or China will advance in the outsourcing sector.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
August
(12)
- Outsourcing of clinical trials expected to rise by...
- Pfizer to create online networking site for clinic...
- Medicare's Stance on Clinical Trials
- Stem cells for the heart in clinical trial
- Biopharma in India is Surging
- goBalto, Matchmaking for CROs and Drug Developers
- India Expected to Take Larger Share of Outsourcin...
- Clinical Trial Cost & Contract Management Agenda F...
- Web Seminar: REMS, EU-RMP and FDAAA: Navigating th...
- Repros Therapeutics Inc. halts clinical trial
- Outsourcing to grow 10% says WSHP
- USA and Europe team together to monitor clinical t...
-
▼
August
(12)
No comments:
Post a Comment